Bentyl Articles
Aventis sells off three drugs for $145 million
13 October 2003
Generics: A Passage Through Time
4 September 1995
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
